Latest Denosumab Stories
An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer.
Inhibiting a protein involved in bone metabolism can delay the onset of the bone metastases which are common in men with a particular form of prostate cancer, a researcher will tell the 2011 European Multidisciplinary Cancer Congress today (Sunday).
OSTORA, a new oral drug made of salmon calcitonin, was in its third phase of study to determine if it effectively treated postmenopausal osteoporosis. The researchers deemed it safe and effective.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.